B
Beppino C. Giovanella
Researcher at St. Joseph Hospital
Publications - 143
Citations - 14095
Beppino C. Giovanella is an academic researcher from St. Joseph Hospital. The author has contributed to research in topics: Camptothecin & Nitrocamptothecin. The author has an hindex of 46, co-authored 143 publications receiving 13698 citations. Previous affiliations of Beppino C. Giovanella include University of Texas MD Anderson Cancer Center & University of Wisconsin-Madison.
Papers
More filters
Journal ArticleDOI
Influence of route of administration on [3H]-camptothecin distribution and tumor uptake in CASE-bearing nude mice: whole-body autoradiographic studies.
Ahmed E. Ahmed,Sam Jacob,Beppino C. Giovanella,Anthony J. Kozielski,John S. Stehlin,Joachim G. Liehr +5 more
TL;DR: This study indicates that CPT is primarily eliminated via the bile, and the gastrointestinal tract is the major site of accumulation and excretion of CPT.
Journal Article
Development of human leukemia U-937 cell sublines resistant to doxorubicin: induction of differentiation and altered sensitivities to topoisomerase-directed drugs.
Panayotis Pantazis,DeJesus A,Janet Early,R Rodriguez,Devasis Chatterjee,Zhiyong Han,James H. Wyche,Beppino C. Giovanella +7 more
TL;DR: It is suggested that several mechanisms are involved in the development of DOX-resistance in U-937 cells, and further, 9-nitrocamptothecin can overcome resistance to DOX.
Journal ArticleDOI
Development of resistance to 9-nitro-camptothecin by human leukemia U-937 cells in vitro correlates with altered sensitivities to several anticancer drugs.
TL;DR: Results in this report indicate that development of 9NC resistance by the U-937 cells is accompanied by increased sensitivities to other anticancer drugs In vitro and very likely In vivo.
Patent
Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
TL;DR: A method of treating human pancreatic cancer with water-insoluble 20(S)-camptothecin compounds with the closed-lactone ring intact and/or derivatives thereof is disclosed in this paper.